Subject of the day
ORX.ST
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
| Line | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | $13.20M | $118.20M | $3.30M | $5.00M |
| Gross profit | $8.50M | $109.80M | $700.00K | $4.60M |
| Operating income | -$76.30M | -$21.50M | -$103.20M | -$74.90M |
| Net income | -$15.90M | -$39.80M | $724.80M | -$133.90M |
| Diluted EPS | -0.46 | -1.15 | -3.33 | -3.81 |
| Free cash flow | -$41.60M | -$700.00K | -$23.60M | -$33.40M |
| CapEx | — | — | — | -$100.00K |
$15.66
▲ +0.02 (+0.1%)
| 52w hi | $41.60 |
|---|---|
| 52w lo | $14.34 |
| Vol | 22.73K |
| As of | Aug 13 |
Our score -0.31
| Short | +0.08 |
|---|---|
| Medium | -0.22 |
| Long | -1.24 |
computed 2026-08-13
Orexo AB (publ)
Healthcare · Drug Manufacturers - Specialty & Generic
| Market cap | $550.09M |
|---|---|
| Enterprise value | $282.38M |
| Trailing P/E | — |
| Forward P/E | -3.66x |
| EV / EBITDA | -0.89x |
| P / S (ttm) | — |
| Profit margin | 2774.7% |
| Return on equity | -1138.6% |
| Revenue growth | -27.1% |
| Earnings growth | — |
| Debt / equity | 3.65 |
| Beta vs SPX | 0.15 |
|---|---|
| Corr SPX | 0.04 |
| Annual vol | 62.1% |
| Annual ret | +24.2% |
| Sharpe | 0.39 |
| Max DD | -63.3% |
Window: 504 trading days (490 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.43 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $15.62 | $15.84 | $14.82 | $15.66 | 22.73K |
| Aug 12 | $14.40 | $16.12 | $14.38 | $15.64 | 63.44K |
| Aug 11 | $14.86 | $14.88 | $14.22 | $14.52 | 22.84K |
| Aug 10 | $14.62 | $14.94 | $14.62 | $14.90 | 8.27K |
| Aug 7 | $14.36 | $14.98 | $14.28 | $14.68 | 24.89K |